December 2009
Cholinesterase Inhibitors Cause Syncope
Cholinesterase inhibitors, such as donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon), which are used to treat Alzheimer's disease, may cause syncope.
In Brief
Cigarettes and Coffee May Elevate Risk of Suicidal Behavior in Patients with Bipolar Disorder; Depression and Anxiety Have Different Effects on Risk of Mortality
Antipsychotics Decrease Mortality
Treatment with antipsychotics increases life expectancy for patients with schizophrenia.
On to 2010!
Dr. Alan Gelenberg reviews biological interventions approved during the past year, including new antipsychotics and a device to deliver repeated transcranial magnetic stimulation (rTMS).
INDEX
2009 Index
Iloperidone (Fanapt)
Iloperidone, an antipsychotic recently approved by the U.S. Food and Drug Administration (FDA), is comparable in efficacy to other second-generation agents.
On to 2010!
December 2009
Hard as it is to believe, 2009 draws to a close. Over the past year, several biological interventions for psychiatric disorders received approval from the U.S. Food and Drug Administration: the antipsychotics iloperidone (Fanapt; see page 47, this issue) and asenapine (Saphris); the antidepressant…
To view the rest of this article, please:
For current
BTP subscribers
Purchase access
to all articles
Purchase this article
for $3 (USD)